PRES Resources

By using the folders below, you can access materials to help you promote PRES at University Hospitals of Leicester NHS Trust.

You can also link directly to the PRES for studies using bespoke QR codes and URLs by using the links below:

• ACTIVE

• ADAPT

• Ad Real

• Alpha 2 agonists for sedation (A2B Trial)

• APP

• ARISE-HF

• ARTISAN

• A-star

• BADBIR

• Baby Panda

• Balance

• BariEX

• Be Sure

• BILAG Biologics Prospective Cohort

• BIOTIPRA Feasibility Trial

• BRAGGS

• BRAID

• Brain TV

• BSRBR-RA - Prospective observational study of the long-term hazards of biological therapies in Rheumatoid Arthritis​

• CAMELOT-MS

• CARLOTA

• CHIEF-PD STUDY

• CONTROL

• CONVINCE

• COOLCUDDLE-2

• COSTED

• COV-BOOST

• CRASH-4

• DAISY-PCOS

• DASH - Desmopressin for treatment of stroke patients on anti-platelet therapy

• DELIVER MS

• DETA

• DISC

• Endeavour

• E.mbrace

• ENSEMBLE 2

• ESPriT2

• ESTEEM

• Exact

• EXPRESS

• FEED1

• FORCE:SEE

• Frailty & INEquality in STroke (FINE-ST)

• GCA Consortium

• Genetics of Endocrine tumours

• GenOMICC

• Genotype-Phenotype correlation in cutaneous allergy

• Giant Cell Arteritis

• GMRx2

• Gristone

• Hands 2

• HbA1c

• HCV RESEARCH UK - Host and viral factors associated with outcomes of infection with hepatitis C virus

• Hep-BV-GMO (GSK)

• HUSH

• HYPER-AID

• IDecide

• Identification of antigen processing independent epitopes for developing antigen specific immunotherapy in Myasthenia Gravis

• IMID (Immune-Mediated Inflammatory Diseases) BioResource

• INFORM

• IONA

• ISARIC Clinical characterization Protocol for Severe Emerging Infection

• ISATS

• KARDIA 2

• MAPS-2

• March

• META 4757

• M20-370

• Move Wales v1

• mRNA1273.529-P206

• MUSC 5128

• Non-adherence

• Nuc-B

• OPTIMAS Trial

• ORA-D

• OUTPASS

• PACKMAN

• PARAMEDIC-3

• Perioperative Quality Improvement Programme: Patient Study

• PETS

• PFP - Parkinsons Family Project

• Phase III Placebo Controlled Study using Siponimod (BAF132) in secondary progressive Multiple Sclerosis

• A Phase 4 Randomized Clinical Trial of Adexanet Alpha

• POWER

• PREPARE

• PRoCURE

• PROFHER2

• PROGRESS

• PROSPECTMUK

• PROSPECTS

• Protocol 18-513 Andexanet ICH

• Psoriasis Study of Health Outcomes: - PSoHO

• REGAL

• RECOVERY

• REDEFINE 2

• REDEFINE 3

• RESILLIENCE

• RESTORE

• R4VaD

• SALT

• SCIENCE

• SERENA

• SETICOS - Study Exploring the Impact of COVID-19 on Stroke

• SHED

• SIREN

• SMART SM

• SOFFT

• A study of direct oral anti-coagulants for patients with a first stroke

• START

• STOP-HCV Cirrhosis study

• SurfON

• SURPASS EARLY

• SURPASS PEDS

• SURPASS WOT

• The diagnostic application of high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS)- based urine analysis in non-adherence to cardiovascular medications

• TICH-3

• TOPAZ

• Trajectories of Outcome in Neurological Conditions

• TWIST

• UK-IRISH A-STAR

• UK JSLE

• UK-REACH V1.0

• UK-ROX

• Vision in Parkinsons

• WAX

• WHiTE 11-FRUITI

• WOMB

• ZEUS